Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi, +30

Leukemia

Hematological MalignancyPrognostic ImpactsGeneticsMedicineGenetic Epidemiology +11

Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow

Kiyotoshi Imai, Masanobu Kobayashi, Jingxin Wang, +8

British Journal of Haematology

ImmunologyBlood CellCellular PhysiologyInflammationHaemopoietic Progenitor Cells +17

Selective Transendothelial Migration of Hematopoietic Progenitor Cells: A Role in Homing of Progenitor Cells

Kiyotoshi Imai, Masanobu Kobayashi, Jingxin Wang, +8

Blood

Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M‐sol)

Hiroshi Azuma, Junichi Hirayama, Mitsuaki Akino, +14

Transfusion

Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT

Satoshi Nishiwaki, Kiyotoshi Imai, Shuichi Mizuta, +14

Bone Marrow Transplantation

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationHematology +9

Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL–positive acute lymphoblastic leukemia

Shuichi Mizuta, Keitaro Matsuo, Satoshi Nishiwaki, +14

Blood

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

Emi Togasaki, June Takeda, Kenichi Yoshida, +29

Blood Cancer Journal

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

Yasuhiko Harada, Yasunobu Nagata, Rika Kihara, +24

Leukemia Research

Hematological MalignancyOncologyCancer EpidemiologyHealth SciencesGenetic Epidemiology +12

Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study

Kazunori Ohnishi, Chiaki Nakaseko, Jin Takeuchi, +14

Cancer Science

PathologyImatinib DosagePharmacotherapyLogistic AnalysisPre-clinical Pharmacology +16

Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.

Han Cw, Masahiro Imamura, Satoshi Hashino, +5

PubMed